FDA Created New Category for ZetrOZ's Long-Duration Pain Management Ultrasound Device
September 29, 2021 08:00 ET
|
ZetrOZ Systems
TRUMBULL, Conn., Sept. 29, 2021 (GLOBE NEWSWIRE) -- ZetrOZ System's Sustained Acoustic Medicine (sam®) device, the only FDA-cleared device of its kind, is part of a new category established by the...
ZetrOZ Systems' SAM Ultrasound Device Successfully Treats Elbow Injury for U.S. Tennis Athlete
September 14, 2021 09:00 ET
|
ZetrOZ Systems
TRUMBULL, Conn., Sept. 14, 2021 (GLOBE NEWSWIRE) -- As a former college tennis player, Kim Dooley suffered elbow injuries throughout her career, including a severed tendon that ended her competitive...
Q BioMed, Inc. CEO Discusses Recently Announced International Market Authorizations and Expansion in to South and Central America and Asia for Q BioMed’s Strontium89, its FDA Approved Drug for the Non-Opioid Treatment of Metastatic Cancer in the Bone
September 22, 2020 07:00 ET
|
Q BioMed Inc.
AUSTIN, Texas, Sept. 22, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Q BioMed Inc. (“the Company”) (OTCQB: QBIO), a commercial...
Q BioMed, Inc. CEO Discusses Recently Announced Global Distribution Partnership with Caligor Coghlan Pharma Services in Audio Interview with SmallCapVoice.com
July 09, 2020 08:00 ET
|
Q BioMed Inc.
AUSTIN, Texas, July 09, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Q BioMed Inc. (“the Company”) (OTCQB: QBIO), a commercial...
Denis Corin, CEO, of Q BioMed Inc. Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com
April 30, 2020 08:00 ET
|
Q BioMed Inc.
NEW YORK, April 30, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Q BioMed Inc. (OTCQB: QBIO) (the "Company"), a commercial stage biotechnology company, announced today that a new audio...